Siga Technologies (SIGA) Cash & Current Investments (2010 - 2025)

Siga Technologies (SIGA) posted Cash & Current Investments of $155.0 million for Q4 2025, down 9.88% on a QoQ basis from $172.0 million in Q3 2025, and little changed year-over-year from $155.4 million in Q4 2024.

Siga Technologies (SIGA) Cash & Current Investments (2010 - 2025) Analysis & Trends

Siga Technologies' Cash & Current Investments history runs 16 years deep, the most recent figure standing at $155.0 million for Q4 2025.

  • Quarterly Cash & Current Investments changed 0.28% year-over-year to $155.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $155.0 million (changed 0.28% YoY) and the FY2025 annual result came in at $155.0 million, changed 0.28% from the prior year.
  • Cash & Current Investments was $155.0 million for Q4 2025 at Siga Technologies, down from $172.0 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $182.5 million in Q2 2025 and bottomed at $71.1 million in Q3 2023.
  • A 5-year average of $123.4 million and a median of $112.1 million in 2022 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments soared 85.59% — and 2023, when it slumped 35.2%.
  • Siga Technologies' Cash & Current Investments stood at $103.1 million in 2021, then declined by 4.22% to $98.8 million in 2022, then soared by 51.98% to $150.1 million in 2023, then increased by 3.5% to $155.4 million in 2024, then retreated by 0.28% to $155.0 million in 2025.
  • Business Quant data shows SIGA's Cash & Current Investments at $155.0 million in Q4 2025, $172.0 million in Q3 2025, and $182.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.78 Bn 87.91 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 36.02 Bn 32.28 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.60 Bn 30.66 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.09 Bn 20.94 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.35 Bn 18.54 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn 428.00 Mn
10 Siga Technologies 224.48 Mn 69.52 Mn - 154.97 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 154.97 Mn
Sep 30, 2025 171.96 Mn
Jun 30, 2025 182.46 Mn
Mar 31, 2025 162.27 Mn
Dec 31, 2024 155.40 Mn
Sep 30, 2024 99.27 Mn
Jun 30, 2024 106.95 Mn
Mar 31, 2024 143.87 Mn
Dec 31, 2023 150.15 Mn
Sep 30, 2023 71.11 Mn
Jun 30, 2023 76.21 Mn
Mar 31, 2023 115.68 Mn
Dec 31, 2022 98.79 Mn
Sep 30, 2022 109.75 Mn
Jun 30, 2022 114.53 Mn
Mar 31, 2022 153.26 Mn
Dec 31, 2021 103.14 Mn
Sep 30, 2021 92.82 Mn
Jun 30, 2021 98.49 Mn
Mar 31, 2021 106.53 Mn